How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?

References

• Ludwig J, Marcotte D E. Anti-depressants, suicide, and drug regulation. Journal of Policy Analysis and Management 2005; 24: 249–272
   PubMed Web of Science ®Google Scholar
• Healy D. Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychotherapy and Psychosomatics 2003; 72: 71–79
   PubMed Web of Science ®Google Scholar
• Tranter R, Healy H, Cattell D, Healy D. Functional effects of agents differentially selective to noradrenergic or serotonergic systems. Psychological Medicine 2002; 32: 517–524
   PubMed Web of Science ®Google Scholar
• Ebmeier K P, Donaghey C, Steele J D. Recent developments and current controversies in depression. Lancet 2006; 367: 153–167
   PubMed Web of Science ®Google Scholar
• MacGillivray S, Arroll B, Hatcher S, et al. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. British Medical Journal 2003; 326: 1014–1017
   PubMed Web of Science ®Google Scholar
• Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials, submitted to the MHRA's safety review. British Medical Journal 2005; 330: 385
   PubMed Web of Science ®Google Scholar
• Klein D F. The flawed basis for FDA post-marketing safety decisions: the example of anti-depressants and children. Neuropsychopharmacology 2005; 31: 689–699
   Google Scholar
• van Praag H M. Why has the antidepressant era not shown a significant drop in suicide rates?. Crisis 2002; 23: 77–82
   PubMedGoogle Scholar
• Ernst C L, Goldberg J F. Antisuicide properties of psychotropic drugs: a critical review. Harvard Review of Psychiatry 2004; 12: 14–41
   PubMed Web of Science ®Google Scholar
• Beasley C M, Jr, Dornseif B E, Bosomworth J C, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. British Medical Journal 1991; 303: 685–692
   PubMed Web of Science ®Google Scholar
• Khan A, Khan S, Kolts R, Brown W A. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. American Journal of Psychiatry 2003; 160: 790–792
   PubMed Web of Science ®Google Scholar
• Fergusson D, Doucette S, Glass K C, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. British Medical Journal 2005; 330: 396
   PubMed Web of Science ®Google Scholar
• Valuck R J, Libby A M, Sills M R, Giese A A, Allen R R. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensityadjusted retrospective cohort study. CNS Drugs 2004; 18: 1119–1132
   PubMed Web of Science ®Google Scholar
• Jick H, Kaye J A, Jick S S. Antidepressants and the risk of suicidal behaviors. Journal of the American Medical Association 2004; 292: 338–343
   PubMed Web of Science ®Google Scholar
• Martinez C, Rietbrock S, Wise L, et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. British Medical Journal 2005; 330: 389
   PubMed Web of Science ®Google Scholar
• Isacsson G, Holmgren P, Ahlner J. Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14 857 suicides. Acta Psychiatrica Scandinavica 2005; 111: 286–290
   PubMed Web of Science ®Google Scholar
• Simon G E, Savarino J, Operskalski B, Wang P S. Suicide risk during antidepressant treatment. American Journal of Psychiatry 2006; 163: 41–47
   PubMed Web of Science ®Google Scholar
• Sondergard L, Kvist K, Andersen P K, Kessing L V. Do antidepressants precipitate youth suicide? A nationwide pharmacoepidemiological study. European Child and Adolescent Psychiatry 2006; 15: 232–240
   PubMedGoogle Scholar
• Strom B L, Melman K L. The use of pharmacoepidemiology to study beneficial drug effects. Pharmacoepidemiology3rd edn., B L Strom. Wiley, Chichester 2000; 553–572
   Google Scholar
• Collet J-P, Boivin J-F. Bias and confounding in pharmacoepidemiology. Pharmacoepidemiology3rd edn, B L Strom. Wiley, Chichester 2000; 765–784
   Google Scholar
• Morgenstern H. Ecologic studies. Modern epidemiology2nd edn., K Rothman, S Greenland. Lippincott-Raven, Philadelphia 1998; 459–480
   Google Scholar
• Strom B L. Other approaches to pharmacoepidemiology. Pharmacoepidemiology3rd edn., B L Strom. Wiley, Chichester 2000; 387–399
   Google Scholar
• Ohberg A, Vuori E, Klaukka T, Lonnqvist J. Antidepressants and suicide mortality. Journal of Affective Disorders 1998; 50: 225–233
   Google Scholar
• Carlsten A, Waern M, Ekedahl A, Ranstam J. Antidepressant medication and suicide in Sweden. Pharmacoepidemiology and Drug Safety 2001; 10: 525–530
   PubMed Web of Science ®Google Scholar
• Fazel S, Grann M, Goodwin G M. Suicide trends in discharged patients with mood disorders: associations with selective serotonin uptake inhibitors and comorbid substance misuse. International Clinical Psychopharmacology 2006; 21: 111–115
   PubMed Web of Science ®Google Scholar
• Rihmer Z. Do SSRIs increase the risk of suicide among depressives even if they are taking only placebo?. Psychotherapy and Psychosomatics 2003; 72: 357–358, author reply 359–360
   Google Scholar
• Hall W D, Mant A, Mitchell P B, et al. Association between antidepressant prescribing and suicide in Australia, 1991–2000:. British Medical Journal 2003; 326: 1008–1011, trend analysis
   PubMed Web of Science ®Google Scholar
• Olfson M, Shaffer D, Marcus S C, Greenberg T. Relationship between antidepressant medication treatment and suicide in adolescents. Archives of General Psychiatry 2003; 60: 978–982
   PubMed Web of Science ®Google Scholar
• Grunebaum M F, Ellis S P, Li S, Oquendo M A, Mann J J. Antidepressants and suicide risk in the United States, 1985–99. Journal of Clinical Psychiatry 2004; 65: 1456–1462
   PubMed Web of Science ®Google Scholar
• Gibbons R D, Hur K, Bhaumik D K, Mann J J. The relationship between antidepressant medication use and rate of suicide. Archives of General Psychiatry 2005; 62: 165–172
   PubMed Web of Science ®Google Scholar
• Barbui C, Campomori A, D'Avanzo B, Negri E, Garattini S. Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates. Social Psychiatry and Psychiatric Epidemiology 1999; 34: 152–156
   PubMed Web of Science ®Google Scholar
• Helgason T, Tomasson H, Zoega T. Antidepressants and public health in Iceland –time series analysis of national data. British Journal of Psychiatry 2004; 184: 157–162
   PubMed Web of Science ®Google Scholar
• Kelly C B, Ansari T, Rafferty T, Stevenson M. Antidepressant prescribing and suicide rate in Northern Ireland. European Psychiatry 2003; 18: 325–328
   PubMed Web of Science ®Google Scholar
• Gunnell D, Middleton N, Whitley E, Dorling D, Frankel S. Why are suicide rates rising in young men but falling in the elderly?–a time-series analysis of trends in England and Wales 1950–1998. Social Science and Medicine 2003; 57: 595–611
   PubMed Web of Science ®Google Scholar
• Morgan O W, Griffiths C, Majeed A. Association between mortality from suicide in England and antidepressant prescribing: an ecological study. BMC Public Health 2004; 4: 63
   PubMed Web of Science ®Google Scholar
• Bostwick J M. Do SSRIs cause suicide in children? The evidence is underwhelming. Journal of Clinical Psychology 2006; 62: 235–241
   Google Scholar
• Raz A. Perspectives on the efficacy of antidepressants for child and adolescent depression. PLoS Medicine 2006; 3: e9
   PubMed Web of Science ®Google Scholar
• Rey J M, Dudley M J. Depressed youth, suicidality and antidepressants. No cause for panic, but an incentive to improve clinical practice. Medical Journal of Australia 2005; 182: 378–379
   PubMedGoogle Scholar
• Whittington C J, Kendall T, Fonagy P, et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004; 363: 1341–1345
   PubMed Web of Science ®Google Scholar
• Jureidini J N, Doecke C J, Mansfield P R, et al. Efficacy and safety of antidepressants for children and adolescents. British Medical Journal 2004; 328: 879–883
   PubMed Web of Science ®Google Scholar
• Hammad T A, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry 2006; 63: 332–339
   PubMed Web of Science ®Google Scholar
• Wohlfarth T D, van Zwieten B J, Lekkerkerker F J, et al. Antidepressants use in children and adolescents and the risk of suicide. European Neuropsychopharmacology 2006; 16: 79–83
   PubMed Web of Science ®Google Scholar
• Gunnell D, Ashby D. Antidepressants and suicide: what is the balance of benefit and harm?. British Medical Journal 2004; 329: 34–38
   PubMed Web of Science ®Google Scholar
• Licinio J, Wong M L. Depression, antidepressants and suicidality: a critical appraisal. Nature Reviews Drug Discovery 2005; 4: 165–171
   PubMed Web of Science ®Google Scholar
• Mann J J, Emslie G, Baldessarini R J, et al. ACNP Task Force Report on SSRIs and Suicidal Behavior in Youth. Neuropsychopharmacology 2006; 31: 473–492
   PubMed Web of Science ®Google Scholar